JEFFREY DAVID JONKER SEC EDGAR Filings (CIK 0001589394)

SEC EDGAR filings, ownership reports, and insider transactions for JEFFREY DAVID JONKER.

Business address
C/O Ngm Biopharmaceuticals, Inc., 333 Oyster Point Blvd., South San Francisco, CA, 94080
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
JEFFREY DAVID JONKER has filed 8 SEC EDGAR filings since 24 Oct 2013

Latest Filings

Recent SEC filings for JEFFREY DAVID JONKER including 4, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 06 Sep 2022 18 May 2022 001-39512
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 25 May 2021 24 May 2021 001-39512
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 18 Mar 2021 17 Mar 2021 001-39512
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 18 Mar 2021 17 Mar 2021 001-39512
4 Open 4 document View SEC filing for 4 FORM 4 - 05 Jun 2014 03 Jun 2014 001-36033
3 Open 3 document View SEC filing for 3 FORM 3 - 14 May 2014 14 May 2014 001-36033
4 Open 4 document View SEC filing for 4 FORM 4 - 24 Oct 2013 22 Oct 2013 000-30319
3 Open 3 document View SEC filing for 3 FORM 3 - 24 Oct 2013 14 Oct 2013 000-30319

About this filer

JEFFREY DAVID JONKER files with the SEC under CIK 0001589394. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages